Is your business truly ready for a sale or outside investment? Manufacturing leaders need to think beyond short-term wins and start building long-term, transferable value, whether a business transition is around the corner or decades away. 

Estelle Black of MedWorld Advisors shares her expertise and best practices to make selling a firm as smooth an experience as possible.

Among the many dynamics impacting the industry is resilience—the key to success of any size OEM or supplier.

In any deal, emotions can run high. But letting them take over could cost you more than your cool—it could cost you the deal itself.

Thank you to all who have been part of our journey! We look forward to continuing to support business owners in the healthcare space around the world.

Congratulations to our partners at Johnson & Johnson MedTech / DePuy Synthes and Ortoma AB on delivering this innovative technology to the market for the benefit of patient outcomes and all stakeholders involved.

MedWorld Advisors serves as advisor to Vascular Technology, Inc, a medical device company specializing in innovative surgical devices and single-use consumables for the operating room, in their sale to middle market PE firm JLL Partners.

Explore how MedTech companies can build long-term intrinsic value through market strategy, financial health, culture, and innovation.

As shown in past economic cycles, M&A will serve as an avenue to adapt to these changes and increase sustainability for businesses and customers alike.

When it comes to your business, value isn’t just about numbers. It’s about what lies beneath. Managing Director Dave Sheppard speaks to building intrinsic value in your medtech manufacturing business on the Moore on Manufacturing podcast.

The current tariff environment underscores the importance of agility, adaptability, and strategic foresight in maintaining and enhancing competitive leadership.

Learn more about how current trade policies and tariffs on medical devices are shaking up U.S. medical device manufacturing.

Good news drives M&A activity and bad news is tolerable as long as it is understood, but uncertainty is the main nemesis of growth.

Factors contributing to manufacturing’s continuous evolution include reproducible, high-quality, AI-enabled technologies; higher product demand; and cost pressures.

It will be exciting to watch this M&A resurgence continue to take shape through 2025 and beyond.

Whether through mergers and acquisitions or spinoffs, the spine sector looks significantly different than it did in 2020.